-transparent.png){kind=logo}
Cognitive and extrapyramidal effects of cholinomimetic therapy were evaluated in 8 patients with progressive supranuclear palsy. Each was randomized to a 10-day double-blind crossover trial of physostigmine and placebo. Physostigmine treatment was associated with marginal and inconsistent changes in long-term memory, suggesting that cholinergic therapy alone is insufficient to restore cognitive function. Motor scores remained unchanged.
Related Publications
I Litvan, and
C Gomez, and
J R Atack, and
M Gillespie, and
A M Kask, and
M M Mouradian, and
T N Chase
June 1989,
La Clinica terapeutica,
I Litvan, and
C Gomez, and
J R Atack, and
M Gillespie, and
A M Kask, and
M M Mouradian, and
T N Chase
December 1990,
Archives of neurology,
I Litvan, and
C Gomez, and
J R Atack, and
M Gillespie, and
A M Kask, and
M M Mouradian, and
T N Chase
July 1991,
Neurology,
I Litvan, and
C Gomez, and
J R Atack, and
M Gillespie, and
A M Kask, and
M M Mouradian, and
T N Chase
September 1982,
Archives of neurology,
I Litvan, and
C Gomez, and
J R Atack, and
M Gillespie, and
A M Kask, and
M M Mouradian, and
T N Chase
January 1971,
Archiv fur Psychiatrie und Nervenkrankheiten,
I Litvan, and
C Gomez, and
J R Atack, and
M Gillespie, and
A M Kask, and
M M Mouradian, and
T N Chase
January 2003,
Ryoikibetsu shokogun shirizu,
I Litvan, and
C Gomez, and
J R Atack, and
M Gillespie, and
A M Kask, and
M M Mouradian, and
T N Chase
October 2003,
Hospital medicine (London, England : 1998),
I Litvan, and
C Gomez, and
J R Atack, and
M Gillespie, and
A M Kask, and
M M Mouradian, and
T N Chase
December 1995,
Rinsho shinkeigaku = Clinical neurology,
I Litvan, and
C Gomez, and
J R Atack, and
M Gillespie, and
A M Kask, and
M M Mouradian, and
T N Chase
May 2003,
Revue neurologique,
I Litvan, and
C Gomez, and
J R Atack, and
M Gillespie, and
A M Kask, and
M M Mouradian, and
T N Chase
January 2013,
Nursing standard (Royal College of Nursing (Great Britain) : 1987),
